Novel linker variants of antileishmanial/antitubercular 7-substituted 2-nitroimidazooxazines offer enhanced solubility
Heteroaryl ether analogues of an antileishmanial 7-substituted 2-nitroimidazooxazine lead afford attenuated hERG risk: In vitro and in vivo appraisal